Skip to main content

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Releases Q4, Full Year 2021 Report

Brain Scientific (OTCQB: BRSF), an innovative company focusing on the medical technology market, is reporting its business highlights and financial results for the fourth quarter and full year ended Dec. 31, 2021. Highlights of the report include BRSF’s merger with Piezo Motion along with the appointment of Hassan Kotob as CEO of the combined company; the company also announced other management appointments with three new independent directors named to the Brain Scientific board and two senior executives appointed to lead revenue generation efforts. In addition, the company partnered with a global master agent to advance innovative neurodiagnostic devices and with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the southern United States. The report also stated that total revenues for the year reached $265,747, compared to $93,664 for the prior year period, with selling, general and administrative expenses coming in at $8,739,705 compared to $2,819,390 in the prior year. R&D expenses for the year totaled $329,425 compared to $210,706 in the prior year. The report also noted a net loss for the year of $9,100,686 compared to a net loss of $2,803,029 in 2020. “2021 was a transformative year, culminating in the merger of Brain Scientific and Piezo Motion,“ said Brain Scientific chair and CEO Hassan Kotob in the press release. “The merger resulted in the creation of a medTech company with two cutting-edge product lines: neurology devices and precision motors, and includes two 510(k) FDA-cleared EEG products. We continue executing an aggressive go-to-market strategy that includes an active channel program with 15 recently signed partners and a global distribution agreement, to gain access to potentially thousands of medical device distributors around the world.”

To view the full press release, visit

About Brain Scientific Inc.

Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultraefficient compact precision motors that will drive the next generation of medical devices. To learn more about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.